| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022733 |
| Receipt No. | R000026188 |
| Official scientific title of the study | Endoscopic assessment based on the status of the Helicobacter pylori infection in patients with functional dyspepsia |
| Date of disclosure of the study information | 2016/06/14 |
| Last modified on | 2018/10/12 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Endoscopic assessment based on the status of the Helicobacter pylori infection in patients with functional dyspepsia | |
| Title of the study (Brief title) | Endoscopic assessment associated with Helicobacter pylori in functional dyspepsia | |
| Region |
|
|
| Condition | ||||
| Condition | Functional dyspepsia | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The aim of this study is to elucidate the endoscopic findings in patients with functional dyspepsia (FD) based on the status of Helicobacter pylori infection. |
| Basic objectives2 | Others |
| Basic objectives -Others | Detection of clinical characteristics |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Endoscopic findings which are mainly included in Kyoto classification of gastritis |
| Key secondary outcomes | The strength of upper gastrointestinal symptoms; reflux and dyspeptic symptoms
The frequency of dyspeptic symptoms |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who underwent esophagogastroduodenoscopy and wrote the questionnaire and informed consent. | |||
| Key exclusion criteria | The patients with serious disease (cancer, heart, lung, liver, and kidney disease)
The patients with organic disease of upper gastrointestinal tract The patients with no consent The patients who underwent surgery of upper gastrointestinal tract The patients who have no assement after the eradication of Helicobacter pylori and the time of eradication is unclear |
|||
| Target sample size | 870 | |||
| Research contact person | |
| Name of lead principal investigator | Fumio TANAKA |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Gastroenterology |
| Address | 1-4-3 Asahimachi, Abeno-ku, Osaka City, Osaka |
| TEL | 06-6645-3811 |
| m2079981@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Fumio TANAKA |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Gastroenterology |
| Address | 1-4-3 Asahimachi, Abeno-ku, Osaka City, Osaka |
| TEL | 06-6645-3811 |
| Homepage URL | |
| m2079981@med.osaka-cu.ac.jp | |
| Sponsor | |
| Institute | Osaka City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Intern Med. 2018 Sep 12. doi: 10.2169/internalmedicine.1325-18. [Epub ahead of print] |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026188 |